Valuation: InMode Ltd.

Market Cap 865M 742M 692M 635M 1.19B 82.63B 1.21B 8.17B 3.2B 41.44B 3.25B 3.18B 137B P/E 2026 *
13.4x
P/E 2027 * 12.5x
Enterprise Value 865M 742M 692M 635M 1.19B 82.63B 1.21B 8.17B 3.2B 41.44B 3.25B 3.18B 137B EV / Sales 2026 *
2.33x
EV / Sales 2027 * 2.28x
Free-Float
60.56%
Yield 2026 *
-
Yield 2027 * -
1 day+0.33%
1 week-1.25%
Current month-0.66%
1 month-2.78%
3 months+7.66%
6 months-0.36%
Current year+2.38%
1 week 14.94
Extreme 14.94
15.31
1 month 14.94
Extreme 14.94
15.6
Current year 12.72
Extreme 12.72
16.67
1 year 12.72
Extreme 12.72
16.74
3 years 12.72
Extreme 12.72
40.4
5 years 12.72
Extreme 12.72
99.27
10 years 6.53
Extreme 6.53
99.27
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 2008-01-01
Chief Executive Officer 73 2008-01-01
Director of Finance/CFO 41 2026-05-18
Director TitleAgeSince
Chairman 73 2008-01-01
Director/Board Member 59 2019-08-06
Chairman 67 2026-05-04
Date Insider Type Main position Quantity % Market Cap.
8/4/26 Free

Chief Financial Officer

14,000 0.0244%
7/30/26 Free

Chairman

2,000 0.0035%
7/30/26 Free

Director

2,000 0.0035%
Change 5-day change 1-year change 3-year change Capi.($)
+0.33%-1.25%+6.06%-59.85% 862M
+4.16%+1.75%+23.13%+15.24% 218B
+5.97%+2.77%-0.33%-15.87% 140B
+1.67%-0.88%-17.00%+39.09% 138B
+3.05%+1.15%-49.87%+3.63% 73.14B
+1.43%-0.83%+16.91%+20.50% 52.44B
+1.32%+2.43%-16.15%-12.15% 50.85B
+4.70%+4.84%+29.39%+30.32% 41.92B
+3.64%-0.07%+39.67%+54.01% 39.42B
+2.74%+3.24%+0.88%+9.16% 32.81B
Average +2.69%+1.11%+3.27%+8.41% 78.77B
Weighted average by Cap. +3.32%+1.28%+2.40%+13.79%

Financials

2026 *2027 *
Net sales 370M 318M 297M 272M 512M 35.39B 520M 3.5B 1.37B 17.75B 1.39B 1.36B 58.69B 379M 325M 303M 278M 523M 36.2B 532M 3.58B 1.4B 18.16B 1.42B 1.39B 60.04B
Net income 68.51M 58.77M 54.87M 50.35M 94.68M 6.55B 96.23M 648M 254M 3.28B 257M 252M 10.86B 71.43M 61.27M 57.21M 52.49M 98.71M 6.83B 100M 675M 264M 3.42B 268M 262M 11.32B
Net Debt - -
Logo InMode Ltd.
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Employees
660
Date Price Change Volume
26-08-19 US$15.04 +0.33% 491,746
26-08-18 US$14.99 -0.20% 375,897
26-08-17 US$15.02 -0.86% 548,989
26-08-14 US$15.15 -0.33% 350,547
26-08-13 US$15.20 -0.20% 347,694
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
15.04USD
Average target price
16.17USD
Spread / Average Target
+7.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INMD Stock